FDA Drug Application (201806) for EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE by HETERO LABS UNIT III

Back to FDA Applications sponsored by HETERO LABS UNIT III

Application Number201806
Product Number001
FormTABLET; ORAL
Dosage200MG; 300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active IngredientEMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE



Back to FDA Applications sponsored by HETERO LABS UNIT III

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.